Announced
ThinkEquity and Roth Capital Partners to acquire a stake in Ampio Pharmaceuticals for $50m.
Synopsis
ThinkEquity, a boutique investment bank, and Roth Capital Partners, a small privately held investment banking company, agreed to acquire a stake in Ampio Pharmaceuticals, a development-stage biopharmaceutical company, for $50m.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
All rights reserved. Copyright © 2025 Datasite